According to a company press release released on Monday, Swedish health technology company H100 Group has secured 144.8 BTC as part of a settlement related to its convertible loan agreement. With this latest deal, the Stockholm-based company now owns a total of 169.2 BTC on its balance sheet.
144.8 BTC was transferred as part of the first four parts of the H100 loan agreement and so far investors have been well gained by investors. H100 stated in a press release that “H100 Group AB (‘H100 Group or “Company”) has received 144.8 BTC today, part of the proceeds of 1 to 4 in accordance with the previously announced convertible loan agreement.”
This is in recent reports that Blockstream CEO Adam returns to a commitment to lead the H100’s 750 million Kronor (about $79 million) funding program, injected by 150 million Kronor from Tranche 6. This loan is structured at speed and cost-effectiveness with a price of 6.38 Kronor, 6.38 Kronor, 33% per share, 33% per share, with a 33% investment company with a 33% confidence-for-trust for your market for your launch.
The loan structure includes settlement flexibility (cash or bitcoin), allowing counterparties to choose BTC delivery, reduce Fiat friction and get along with the company’s long-term fiscal outlook.
“Unexpectedly, given the strong reception, 1-4 batches quickly became currency currencies,” Back told Coindesk. “I’m looking forward to it [H100] As they reach monetary status, they will switch over time. ”
This financing method allows the H100 to flexibly bypass capital while bypassing traditional rights issues. 7 and 8 batches on the deck are on the deck, with the size of space increasing depending on the market appetite.
This also reflects the ever-evolving financial strategy of H100. While the company’s core operations are still focused on AI-driven health and lifespan services, its growing Bitcoin position is reshaping how capital is raised, stored and deployed. As of now, the company has BTC holdings of 169.2 BTC, only 24.41 BTC before this latest batch execution.
H100 shares rose 22% in response to development on Monday.
As the company continues to negotiate future batches and explores the adoption of BTC as a financial backbone, it is uniquely positioned at the intersection of health technology and decentralized finance.
